Skip to main content
. 2020 Mar 25;12(4):297. doi: 10.3390/pharmaceutics12040297

Figure 2.

Figure 2

Quetiapine plasma concentration time profiles in a typical patient following the administration of 200 mg BID IR (solid line) and 400 mg QD XR (dashed line) formulations, assuming dose adherence (A), delay (B), omission (C), doubling (D) and discontinuation (E).